ADRs End Mostly Higher; Barclays Rises

International stocks trading in New York closed mostly higher on Monday.

Barclays PLC (BCS) was among the companies with ADRs that traded actively.

The BNY Mellon index of American depositary receipts edged up 0.09% to 127.23. The European index eased 0.21% to 121.62; the Asian index rose 0.63% to 140.95; the Latin American index increased 0.61% to 202.46; and the emerging markets index rose 0.42% to 249.97.

Barclays agreed to pay $100 million to end investigations by 43 states and the District of Columbia into its alleged manipulation of the London interbank offered rate benchmark in the mid-2000s, authorities said on Monday. The settlement comes four years after the British bank resolved similar charges with U.S. and U.K. authorities that had ignited a firestorm and led to the resignation of its top leadership. Attorneys general from multiple states led by New York and Connecticut launched their own probes in 2012 in the wake of those charges. ADRs rose 3.2% to $8.35 amid a broker upgrade earlier on Monday.

ADRs of Novo Nordisk AS (NVO, NOVO-B.KO) fell 5.5% to $47.13 on Monday, declining for a second day, after the Danish pharmaceutical company on Friday lowered its 2016 revenue estimate to the lower end of its previous guidance, citing tough market conditions in the U.S. Analysts at Leerink said the downbeat outlook raised questions about Novo's long-term goal of increasing its operating profit by 10% within five years.

Write to Tess Stynes at [e-mail]

(END) Dow Jones Newswires

August 08, 2016 18:12 ET (22:12 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.